Home/Pipeline/Antibiotic discovery programme

Antibiotic discovery programme

Bacterial virulence inhibition

PreclinicalActive

Key Facts

Indication
Bacterial virulence inhibition
Phase
Preclinical
Status
Active
Company

About Qbiotics

Australian biotech leveraging rainforest‑derived small molecules for oncology and wound‑healing therapies.

View full company profile

Therapeutic Areas